Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Synergy Pharmaceuticals (SGYP) Ready To Roll

(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, reported today that Synergy Pharmaceuticals (SGYP) may be in a position to realize significant share price gains over the coming months.



Synergy Pharmaceuticals (SGYP) ran to over seven dollars last month on increasing volume as the company's billion dollar potential took shape and numerous analysts jumped on board with encouraging write-ups and bold price predictions.



Synergy also received a boost when its chief competitor, Ironwood Pharmaceuticals (IRWD) received a setback at the FDA that allows SGYP an extra three months to play catch up in the race to commercialization for each company's respective product candidate, both of which target the same indication. Synergy's product Plecanatide, however, has a much more favorable side effect profile, making the Ironwood setback that much more of a key factor when discussing future market potential.



Both products, Synergy's Plecanatide and Ironwood's Linaclotide, are being developed to treat chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C). Linaclotide is already before the FDA for review, although the review was delayed by three months, as mentioned before, while Phase II/III Plecanatide results are due out later this year.



The head start to market may provide Ironwood with a distinct advantage, but the advantage might not last too long when Plecanatide shows up on the scene.



During the Linaclotide trials, the drug was successful in alleviating symptoms relating to IBS-C and CIC when compared to a placebo, but the kicker is that patients experienced side effects that included cases of extreme diarrhea, essentially reversing the symptom being treated. Some cases of diarrhea were so bad that 6% of the patients decided to abandon the trial altogether.



On the open market - with a competing product out there for which there have been no such cases noted - that means those patients would likely switch to the alternative, in this case Plecanatide, that is not associated with carrying around a roll of Charmin' Soft at all times.



For full report visit: http://vfcsstockhouse.com/blog/article/-synergy-pharmaceuticals-sgyp-may-be-ready-to-roll



For full report and opinion visit: http://vfcsstockhouse.com/blog/article/-the-facebook-fb-ipo-don-t-believe-the-hype



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



For full disclaimer visit: http://vfcsstockhouse.com







VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Spanish judge orders release of ill boy's parents
2 Sep 2014 at 11:30am

SOTO DEL REAL, Spain (AP) ? Spanish officials have ordered the immediate release of a detained British couple who were wanted by police in the United Kingdom after they took their critically ill child for treatment abroad without doctors' consent.


Ebola outbreak 'pretty much contained' in Senegal and Nigeria
22 Sep 2014 at 10:58am
GENEVA (Reuters) - Two of the five countries affected by the world's worst-ever Ebola outbreak are managing to halt the spread of the disease, the World Health Organization said on Monday, although the overall death toll has risen to 2,811 out of 5,864 cases. "On the whole, the outbreaks in Senegal and Nigeria are pretty much contained," said an update from WHO's regional director in Africa. ...


Siemens splurges $7.6 billion on Dresser-Rand in U.S. shale market bet
22 Sep 2014 at 10:50am

By Georgina Prodhan and Ludwig Burger FRANKFURT (Reuters) - Germany's Siemens AG has agreed to buy U.S. oilfield equipment maker Dresser-Rand Group Inc for $7.6 billion in cash, paying a relatively rich price to belatedly beef up its presence in the U.S. shale oil and gas industry. The acquisition, which ranks among the biggest in the history of the industrial group, will strengthen Siemens' position in the United States, its weakest region, and bring it nearer catching up with rival General Electric Co . ...



Streets bustling after Sierra Leone shutdown ends
22 Sep 2014 at 10:49am

FREETOWN, Sierra Leone (AP) ? Streets in Sierra Leone's capital bustled again Monday after an unprecedented nationwide shutdown during which officials said more than 1 million households were checked for Ebola patients and given information on how to prevent the spread of the deadly disease.


Some Gut Microbes Love Diet Soda... and They're Not the Good Guys
22 Sep 2014 at 10:41am
Consumers are getting increasingly more worried about sugar. That's led to consumption of ever-growing amounts of non-caloric sweeteners such as Equal, Splenda, Sweet'N Low and Stevia. It's a whole-population uncontrolled experiment, long underway, with some mystifying outcomes:Diet drinks are associated with weight gain in...


Germany's Merck to buy Sigma-Aldrich for $17 billion to boost lab supplies op...
22 Sep 2014 at 9:56am

By Ludwig Burger FRANKFURT (Reuters) - Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history. The deal helps Merck, 70 percent controlled by the descendants of its 17th century founder, to focus more on supplying drugmakers and academic institutions with chemicals and services, seen as offering a steadier income stream than drug development. ...


Alaska TV reporter curses, quits on air over marijuana issue
22 Sep 2014 at 9:33am
By Daniel Wallis (Note: Strong language in paragraph four) Reuters) - An Alaska television reporter wrapped up a live segment on medical marijuana with a curse and an "I quit," telling viewers she will work instead to legalize pot in the state. Charlo Greene revealed she was in fact the owner of the "cannabis club" featured in her story on Anchorage's KTVA 10 p.m. broadcast Sunday. "I ... will be dedicating all of my energy toward fighting for freedom and fairness, which begins with legalizing marijuana here in Alaska," the reporter said. ...

Smartphone app may allow parents to screen newborns for jaundice
22 Sep 2014 at 9:25am
By Rob Goodier NEW YORK (Reuters Health) ? A new smartphone application still in development may someday help parents and health care providers screen for jaundice in newborns. Early testing found that the application has greater accuracy than visual exams performed by doctors, according to research presented September 16 at the International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp 2014) in Seattle, Washington. Dr. ...


Ebola kills 2,793, 'pretty much contained' in Senegal, Nigeria: WHO
22 Sep 2014 at 9:04am

Geneva (AFP) - The deadliest Ebola epidemic ever has now killed 2,793 in west Africa, the World Health Organization said Monday, adding though that in Senegal and Nigeria the outbreak had been basically contained.



Sierra Leone faces 'overflow' of Ebola dead as curfew ends
22 Sep 2014 at 8:54am

Freetown (AFP) - Millions of Sierra Leoneans emerged from their homes on Monday after a controversial nationwide lockdown during which scores of dead bodies and around 150 new cases of Ebola infections were uncovered.


Auxilium says Endo offer undervalues company, but open to talks
22 Sep 2014 at 8:22am
(Reuters) - Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's $2.2 billion takeover offer "significantly undervalues" the company, but left the door open for talks on a possible deal. Endo, which is seeking to expand its men's healthcare products business, made an unsolicited offer for Auxilium last week, prompting the company to adopt a "poison pill" takeover defense. Auxilium said it maintained the right to engage in discussions with Endo, while Endo said it was willing to work with Auxilium on a deal. ...


U.S., Canada allow emergency use of Tekmira's Ebola treatment
22 Sep 2014 at 7:12am

(Reuters) - Canadian drugmaker Tekmira Pharmaceuticals Corp said on Monday that U.S. and Canadian regulators have authorized the use of its Ebola treatment in patients who have confirmed or suspected infections from the deadly virus. The Vancouver-based company said its treatment, TKM-Ebola, has been administered to patients on an emergency basis and the repeat infusions have been well-tolerated. Expanded access protocols, authorized by the U.S. ...


Merck still sees investment grade ratings after Sigma-Aldrich deal
22 Sep 2014 at 6:51am
FRANKFURT (Reuters) - Drugs and chemicals maker Merck KGaA expects its credit ratings to remain at investment grade levels following its planned acquisition of Sigma-Aldrich , its finance chief said. "We will face a downgrade by the credit rating agencies, however this downgrade will be moderate," Merck Chief Financial Officer Marcus Kuhnert said during a conference call on Monday. "We will absolutely maintain our solid investment grade rating," he said. ...


Sierra Leone records 130 new Ebola cases during 3-day lockdown
22 Sep 2014 at 6:37am

FREETOWN (Reuters) - Sierra Leone recorded 130 new cases of the Ebola virus during a three-day lockdown and it is waiting for test results on a further 39 suspected cases, Stephen Gaojia, head of the Ebola Emergency Operations Centre, said on Monday. The country had ordered its six million citizens to stay indoors until Sunday night in the most extreme strategy employed by a West African nation since the start of an epidemic that has infected 5,762 people since March and killed 2,793 of those. "The exercise has been largely successful ... The outreach was just overwhelming. ...



Europe reviewing resources for fight against Ebola -Italy minister
22 Sep 2014 at 6:35am

MILAN (Reuters) - European countries are assessing what resources they have to help fight Ebola and are planning a coordinated response to the worst outbreak of the virus in history, Italy's health minister Beatrice Lorenzin said on the sidelines of a meeting on Monday. The European Union has pledged 140 million euros ($180 million) to reinforce the fight against Ebola in West Africa, where the haemorrhagic fever has killed at least 2,793 people in five countries, according to the World Health Organisation. "Only four or five countries in Europe are equipped. ...


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC